Phosphodiesterase-4 Inhibition Combined with Isoniazid Treatment of Rabbits with Pulmonary Tuberculosis Reduces Macrophage Activation and Lung Pathology
- 31 July 2011
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 179 (1), 289-301
- https://doi.org/10.1016/j.ajpath.2011.03.039
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (RO1 54338)
- Bill and Melinda Gates Foundation (RO1 54338)
- National Institutes of Health (RO1 54338)
This publication has 72 references indexed in Scilit:
- STAT3, p38 MAPK, and NF-κB Drive Unopposed Monocyte-Dependent Fibroblast MMP-1 Secretion in TuberculosisAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- How tumour necrosis factor blockers interfere with tuberculosis immunityClinical and Experimental Immunology, 2010
- Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogensNature Immunology, 2008
- PDE4 inhibitors: current statusBritish Journal of Pharmacology, 2008
- Differential Expression of Interleukin-4 (IL-4) and IL-4δ2 mRNA, but Not Transforming Growth Factor Beta (TGF-β), TGF-βRII, Foxp3, Gamma Interferon, T-bet, or GATA-3 mRNA, in Patients with Fast and Slow Responses to Antituberculosis TreatmentClinical and Vaccine Immunology, 2008
- Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarringThe Journal of Experimental Medicine, 2008
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- Metalloproteinases and their inhibitors: Regulators of wound healingThe International Journal of Biochemistry & Cell Biology, 2007
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003